Adam talks to Professor Gino Martini, Chief Scientific Officer for the Royal Pharmaceutical Society, the body that supports pharmacists across the UK as well as championing pharmacy across media and government and leading the way in medicines information.
Professor Martini talks about his career, the effect the pandemic will have on the speed of drug development and what the future of community pharmacy will look like. He also talks about how the pharmaceutical industry is embracing precision medicine and evolving with the introduction of various diagnostic tools that give us the opportunity to detect earlier and stratify patients better.
Subscribe to the podcast
[podcast]
“What has really encouraged me, is the great collaboration between pharma with academia and other research groups. It’s been really good to see people working together, GSK working with Sanofi, AstraZeneca working other organisations in a collaborative way, sharing resources, sharing ideas, and just getting the job done in a coordinated, open, collaborative way, I think has been fantastic.”
Professor Gino Martini